| Literature DB >> 17468445 |
L Roccatagliata1, Ma Rocca, P Valsasina, L Bonzano, Mp Sormani, R Saccardi, Gl Mancardi, M Filippi.
Abstract
Using MRI, we measured disease activity and brain atrophy in nine multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT) for a mean follow up of 63 months. We show that AHSCT is associated to a longlasting suppression of inflammation and to a marked decrease of the rate of brain atrophy after the second year following treatment.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17468445 DOI： 10.1177/1352458507076982
Source DB: PubMed Journal: Mult Scler ISSN： 1352-4585 Impact factor: 6.312